95 related articles for article (PubMed ID: 28429105)
1. Increased expression of uPA, uPAR, and PAI-1 in psoriatic skin and in basal cell carcinomas.
Rubina KA; Sysoeva VY; Zagorujko EI; Tsokolaeva ZI; Kurdina MI; Parfyonova YV; Tkachuk VA
Arch Dermatol Res; 2017 Aug; 309(6):433-442. PubMed ID: 28429105
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen Activation System in Rectal Adenocarcinoma.
Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
[TBL] [Abstract][Full Text] [Related]
3. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
Pavón MA; Arroyo-Solera I; Céspedes MV; Casanova I; León X; Mangues R
Oncotarget; 2016 Aug; 7(35):57351-57366. PubMed ID: 27385000
[TBL] [Abstract][Full Text] [Related]
4. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of urokinase-type plasminogen activator receptor in bovine cumulus-oocyte complexes.
García DC; Miceli DC; Rizo G; García EV; Valdecantos PA; Roldán-Olarte M
Zygote; 2016 Apr; 24(2):230-5. PubMed ID: 25939353
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
[TBL] [Abstract][Full Text] [Related]
7. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
8. Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas.
Sereff SB; Daniels MW; Wittliff JL
J Clin Lab Anal; 2019 Nov; 33(9):e22982. PubMed ID: 31359505
[TBL] [Abstract][Full Text] [Related]
9. uPA/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action.
Dinesh P; Rasool M
Pharmacol Res; 2018 Aug; 134():31-39. PubMed ID: 29859810
[TBL] [Abstract][Full Text] [Related]
10. Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.
Zhou L; Guo H; Jia F; Chen X; Zhang X; Dong S; Zhao L
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146708
[TBL] [Abstract][Full Text] [Related]
11. SuPAR, a potential inflammatory mediator in psoriasis pathogenesis.
Hamie L; Eid E; Abbas O; Safi R; Nammour T; Tamim H; Makki M; Stephan C; Hasbani D; Wehbe H; Ghaoui N; Hawa M; Nasser N; Eid A; Kibbi AG; Kurban M
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1705-1712. PubMed ID: 32558953
[TBL] [Abstract][Full Text] [Related]
12. The plasminogen activation system in tumor growth, invasion, and metastasis.
Andreasen PA; Egelund R; Petersen HH
Cell Mol Life Sci; 2000 Jan; 57(1):25-40. PubMed ID: 10949579
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.
Mahmood N; Rabbani SA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33921923
[TBL] [Abstract][Full Text] [Related]
14. Computational Approaches and Analysis for a Spatio-Structural-Temporal Invasive Carcinoma Model.
Hodgkinson A; Chaplain MAJ; Domschke P; Trucu D
Bull Math Biol; 2018 Apr; 80(4):701-737. PubMed ID: 29500719
[TBL] [Abstract][Full Text] [Related]
15. The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications.
Li Santi A; Napolitano F; Montuori N; Ragno P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923400
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.
Gonias SL
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C721-C734. PubMed ID: 34406905
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
Hugdahl E; Bachmann IM; Schuster C; Ladstein RG; Akslen LA
PLoS One; 2019; 14(1):e0210399. PubMed ID: 30640942
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions.
Costa CSO; Mafra RP; Rolim LSA; Souza LB; Pinto LP
Braz Oral Res; 2022; 36():e071. PubMed ID: 36507758
[TBL] [Abstract][Full Text] [Related]
19. Plasmin and Plasminogen System in the Tumor Microenvironment: Implications for Cancer Diagnosis, Prognosis, and Therapy.
Bharadwaj AG; Holloway RW; Miller VA; Waisman DM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921488
[TBL] [Abstract][Full Text] [Related]
20. FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice.
Malik B; Vokic I; Mohr T; Poppelaars M; Holcmann M; Novoszel P; Timelthaler G; Lendl T; Krauss D; Elling U; Mildner M; Penninger JM; Petzelbauer P; Sibilia M; Csiszar A
EMBO Mol Med; 2023 Jul; 15(7):e16758. PubMed ID: 37226685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
